Conference Call on Thursday, August 10, 2023, at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, August 10, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today reported financial results for the second quarter of 2023, ended June 30, 2023. Second Quarter and Recent Highlights Transplant product launch on pace for Q4 early … Continue reading “Oncocyte Reports Second Quarter 2023 Financial Results”
Breaking News
Breaking News
Mike The Pike Productions, Inc. (OTC: MIKP) Arowana Media Holdings Announces Acquisition of Rights to ‘Biker’ Mystery Series by Legendary Creator Mike Baron
Mike The Pike acquires book series by Eisner Award winning author/writer behind The Punisher, The…
August 9, 2023
Breaking News
ONCOCYTE REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS
IRVINE, CA, August 9, 2023 – Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced…
August 9, 2023
Breaking News
PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study
PaxMedica to discuss significance of Phase 3 study results Interview to be webcast on Tuesday,…
August 8, 2023
Breaking News
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
CEO Josh Riggs will be meeting with registered investors on Tuesday, August 15, 2023 IRVINE,…
August 8, 2023
Breaking News
Titan NRG, Inc. (TTNN) Acquires New Equipment
TUCSON, AZ, August 7, 2023 – Titan NRG, Inc. (OTC PINK:TTNN) (“Titan NRG”) a leader…
August 7, 2023